SecBot SecBot

AHCO

AdaptHealth Corp.
Nasdaq· Services-Home Health Care Services· Inc. DE· CIK 0001725255 Healthcare & Medical Devices
$7.73 +0.07 (+0.91%)
Nov 16 4:00 PM ET · prev $7.66
Market cap
$1.1B
Small cap
Consensus
Buy
92% Buy or better · 13 analysts
Median target
$9.00
+16% · range $8.00–10.00
1 year
−17.1%
from $9.33 · Nov 17
30 days
+31.5%
from $5.88
52-week range
$5.22–13.38
−42% from high · low Aug 10
Avg volume 20D
2.73M
Nov 3 spike 7.67M
Short interest
10.93M
≈8.0% of shares · +6.8%
Days to cover
5.2
at average volume
Insider net
+$49.0M
5 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
20
analyzed by SecBot
SecBot read MIXED 11 reports · 90 days
Balance 2 bearish · 0 bullish · 1 mixed · 8 neutral oldest → newest, height = score
Avg score ·High conf. 6/11

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    5 insiders bought $49.2M at an average $9.71. 1 insider sold $231.1K. Price is 20% below their cost.

  • InstitutionsBULLISH

    Q3 2026: 39 added (0 new), 18 trimmed or exited.

  • AnalystsBULLISH

    12 of 13 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest +6.8% to 10.93M shares. 5.2 days to cover, ≈8.0% of shares.

  • TrendUPTREND

    25% above its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
FMR LLCADD10,814,727$61.0M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM3,861,468$21.8M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD3,206,278$18.1M
UBS Group AGDOUBLED707,165$4.0M
CITIGROUP INCDOUBLED494,239$2.8M
FIRST TRUST ADVISORS LPADD451,670$2.5M
Nuveen, LLCADD384,305$2.2M
Vanguard Global Advisers, LLCADD316,313$1.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 92% rate it Buy or better
Strong Buy5Buy7Hold1Sell0Strong Sell0
12-month targets · 7 analysts

Price is below the lowest target. Median implies +16%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 5, 2026Leerink Partners
MAINTAIN
MAINTAINOutperform
Nov 4, 2026UBS
MAINTAIN
MAINTAINBuy
Sep 17, 2026Baird
MAINTAIN
MAINTAINOutperform
Aug 6, 2026UBS
MAINTAIN
MAINTAINBuy
Aug 6, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Aug 5, 2026Truist Securities
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$49.2M
bought · 5 insiders
$231.1K
sold · 1 insider
−20.4%
vs their $9.71 cost
DateInsiderTypeValue
Sep 9, 2026
CURRIE HARRISS T
CHIEF FINANCIAL OFFICER
Sep 9, 2026
AWARD141,372 sh
Aug 7, 2026
WOLF DALE B
Director
Aug 7, 2026
BUY$117.2K
Aug 6, 2026
SAMET KENNETH A
Director
Aug 6, 2026
BUY$149.9K
Aug 6, 2026
WOLF DALE B
Director
Aug 6, 2026
BUY$126.0K
Jul 1, 2026
Schuster III Russell E.
Chief Commercial Officer
Jul 1, 2026
SELL$117.7K
Jun 24, 2026
BELINFANTI GREGORY
Director
Jun 24, 2026
AWARD18,999 sh
Jun 24, 2026
Connors Terence J
Director
Jun 24, 2026
AWARD18,999 sh
Jun 24, 2026
Williams David Solomon III
Director
Jun 24, 2026
AWARD18,999 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q-$0.09-$0.13–-$0.07+0.0%$720.5M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
10,928,383
shares short
+6.8%
vs prior settlement
5.2
days to cover
≈8.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Former CFO Jason A. Clemens filed a Form 144 notice of intent to sell 10,000 shares of AdaptHealth Corp. common stock…
144 · Impact 2/10
Nov 12, 2026 SEC
Jason A. Clemens, former CFO of AdaptHealth Corp., filed a Form 144 notice to sell 19,855 shares valued at…
144 · Impact 3/10
Nov 3, 2026 Earnings result
AHCO Q3 2026 Earnings: EPS $-0.13 (-1192.4% vs est)
Oct 29, 2026 Event
(PS) Pete v. Adapthealth Corp.
Court ruling (caed). Docket: 2:26-cv-03244
Sep 30, 2026 Inst.
FMR LLC · ADD
10,814,727 shares ($61.0M)
Sep 30, 2026 Inst.
VANGUARD PORTFOLIO MANAGEMENT LLC · TRIM
3,861,468 shares ($21.8M)
Sep 9, 2026 Insider
CURRIE HARRISS T was granted 141,372 shares
CHIEF FINANCIAL OFFICER
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

20 filings · 3 bullish · 4 bearish · 2 mixed · 11 neutral
All AHCO filing & press-release reports (20)